Unraveling Anabolic Resistance in Sarcopenia: A Narrative Synthesis of Age-Related Impairments in Muscle Protein Synthesis

Article information

Asian J Kinesiol. 2025;27(3):107-113
Publication date (electronic) : 2025 July 31
doi : https://doi.org/10.15758/ajk.2025.27.3.107
Department of Sports Medicine, Soonchunhyang University, Asan, Republic of Korea
*Correspondence: Hyun-Joo Kang, Department of Sports Medicine, Soonchunhyang University, Asan, Republic of Korea; Tel: +82-10-7920-1280; E-mail: violethjk@naver.com
Received 2025 July 7; Revised 2025 July 14; Accepted 2025 July 31.

Abstract

OBJECTIVES

Anabolic resistance, characterized by the diminished muscle protein synthesis (MPS) response to anabolic stimuli, represents the fundamental pathophysiological mechanism underlying age-related sarcopenia. This condition has a significant impact on clinical outcomes, including increased healthcare costs, disability, and mortality. To synthesize current clinical evidence on anabolic resistance mechanisms and evaluate evidence-based therapeutic interventions for its mitigation.

METHODS

This narrative synthesis was conducted by reviewing peer-reviewed clinical and translational studies published between January 2010 and March 2025. A structured search was performed in PubMed and Scopus using combinations of the keywords: “anabolic resistance”, “muscle protein synthesis”, “sarcopenia”, “resistance training”, “aging”, and “protein intake”.

RESULTS

Anabolic resistance manifests as an elevated protein threshold requirement (0.40 g/kg/day per meal vs. 0.24 g/kg/day in young adults) and reduced exercise-induced MPS stimulation. Physical inactivity amplifies this resistance through a feed-forward mechanism. Clinical evidence demonstrates that resistance training acts as the primary intervention to restore anabolic sensitivity, with effects lasting 24-48 hours post-exercise. Optimal protein distribution (1.2-1.6 g/kg/day divided into 0.4 g/kg/day per meal) is essential to overcome the elevated anabolic threshold. Creatine monohydrate supplementation provides additional benefits when combined with resistance training.

CONCLUSIONS

Anabolic resistance represents a modifiable clinical target. Evidence-based interventions combining resistance training with optimized protein nutrition can effectively restore anabolic sensitivity and prevent sarcopenia progression. Future research should focus on personalized approaches and long-term clinical outcomes.

Introduction

Sarcopenia affects approximately 10-16% of older adults globally and is projected to impact over 200 million individuals by 2050 [1,2]. Beyond its clinical manifestations of muscle wasting and functional decline, sarcopenia represents a distinct pathophysiological entity characterized by fundamental alterations in muscle anabolism. The concept of anabolic resistance has emerged as the central mechanism explaining why conventional nutritional and exercise interventions often fail in older adults [3].

Anabolic resistance refers to the diminished muscle protein synthesis (MPS) to essential anabolic cues, such as dietary amino acids or mechanical loading [4]. As a result, the balance tips toward catabolism, gradually eroding muscle mass and function over time [5]. Clinically, this underlies why standard nutritional and exercise prescriptions often fall short of what older adults. The reality is that this subtle yet widespread resistance requires a fundamentally approach if we are to develop effective strategies for preserving muscle health as people age.

Search Procedures and Study Eligibility Criteria

This narrative synthesis was conducted by reviewing peerreviewed clinical and translational studies published between January 2010 and March 2025. A structured search was performed in PubMed and Scopus using combinations of the keywords: “anabolic resistance”, “muscle protein synthesis”, “sarcopenia”, “resistance training”, “aging”, and “protein intake”. Studies were included if they (1) investigated mechanisms or interventions related to anabolic resistance in older adults, and (2) reported outcomes related to muscle protein synthesis, strength, or sarcopenia-related clinical markers. Non-English articles, animal-only studies, and case reports were excluded. Findings were synthesized thematically according to mechanistic pathways, diagnostic approaches, and clinical interventions.

Pathophysiology of Anabolic Resistance

Molecular mechanisms

The molecular basis of anabolic resistance involves multiple interconnected pathways affecting muscle protein turnover. Age-related changes in the mechanistic target of rapamycin (mTOR) signaling pathway represent a primary mechanism [6]. In younger adults, protein ingestion rapidly activates mTOR through amino acid sensing, particularly leucine-mediated signaling [7]. However, older adults demonstrate impaired mTOR activation, requiring higher amino acid concentrations to achieve comparable responses [6].

Additionally, age-related alterations in muscle blood flow and amino acid transport contribute to anabolic resistance [8,9]. Capillary density decreases with aging, reducing nutrient delivery to muscle fibers [10]. Simultaneously, amino acid transporter expression and function decline, limiting the muscle’s capacity to extract circulating amino acids even when adequate protein is consumed [11].

Figure 1.

Mechanistic Pathways Underlying Anabolic Resistance in Aging Skeletal Muscle.

Clinical manifestations

Clinically, anabolic resistance reflects a diminished MPS response to typical protein doses, indicating a shift in the dose-response relationship [4,12]. While young adults achieve maximal MPS stimulation with approximately 0.24 g/kg of highquality protein per meal, older adults require nearly double this amount (0.40 g/kg) to achieve equivalent responses [13].

This elevated threshold has profound implications for clinical practice. Standard dietary recommendations based on younger adult populations become inadequate for older adults, potentially contributing to progressive muscle loss despite seemingly adequate protein intake.

The inactivity-resistance cycle

Physical inactivity represents a potent amplifier of anabolic resistance, creating a pathological feed-forward cycle [9]. Even short periods of reduced activity (14 days) can induce measurable anabolic resistance in previously healthy older adults [14]. This inactivity-induced resistance persists beyond the period of reduced activity, suggesting deeper metabolic changes rather than simple reversible deconditioning.

This creates a vicious cycle through several interconnected problems. When people become less active, the reduced mechanical stress on muscles makes mTOR signaling even less sensitive [6], while decreased muscle blood flow limits amino acid delivery and uptake [8,9]. Prolonged inactivity also triggers inflammatory responses that further compromise anabolic signaling pathways, creating a pattern where muscle becomes increasingly resistant to anabolic stimuli.

This cycle poses particular risks for older adults who may face periods of enforced inactivity due to illness, hospitalization, or injury. Breaking this pattern requires early intervention with structured resistance training and targeted nutritional support to restore anabolic sensitivity before irreversible changes occur. This mechanism highlights why maintaining regular physical activity is critically important throughout aging.

Clinical Assessment of Anabolic Resistance

Diagnostic challenges

Unlike other age-related conditions, anabolic resistance lacks standardized diagnostic criteria or easily accessible biomarkers. Current research relies primarily on stable isotope methodology to measure MPS rates, which is limited to specialized research facilities [15]. This creates a significant gap between research understanding and clinical application.

Surrogate markers

Several potential surrogate markers have been proposed for clinical assessment of anabolic resistance. Functional Measures such as grip strength, gait speed, and sit-to-stand performance may reflect the cumulative effects of anabolic resistance on muscle mass and quality [16]. However, these measures lack specificity and may be influenced by multiple factors beyond muscle anabolism.

Circulating amino acid profiles, particularly branchedchain amino acid concentrations, may provide insights into muscle anabolic capacity [17]. However, validation studies are lacking, and normal variation limits clinical utility. Dual-energy X-ray absorptiometry (DXA) and bioelectrical impedance analysis (BIA) can assess muscle mass but fail to capture muscle quality or anabolic capacity [18]. More sophisticated imaging techniques, such as magnetic resonance imaging (MRI) or computed tomography (CT), can assess muscle quality but remain expensive and inaccessible for routine clinical use.

Evidence-Based Interventions

Resistance training: the primary intervention

Among all non-pharmacological strategies, resistance training remains the cornerstone in reversing anabolic resistance. Notably, even a single session can re-sensitize aging muscle to anabolic signals—particularly amino acids—for up to 48 hours. This transient “window of opportunity” underscores the importance of consistent and strategically timed interventions [19].

Resistance training exerts its anabolic effects through multiple integrated mechanisms that collectively restore muscle sensitivity to anabolic stimuli [20]. The primary mechanism involves direct mechanical stimulation of the mechanistic target of rapamycin (mTOR) signaling pathway, where mechanical tension and stretch activate mTOR complex 1 (mTORC1) through a cascade involving focal adhesion kinase (FAK) and phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling [5,21]. This mechanical activation bypasses the agerelated impairments in amino acid-induced mTOR stimulation, providing an alternative pathway for initiating muscle protein synthesis [22].

Simultaneously, resistance exercise enhances muscle perfusion and nutrient delivery through acute vasodilation and chronic adaptations in capillary density. The exerciseinduced increase in muscle blood flow facilitates the delivery of circulating amino acids to the muscle tissue, while the mechanical stress of contraction enhances microvascular recruitment and endothelial function [23]. These vascular adaptations are particularly important in aging muscle, where baseline perfusion is often compromised.

Furthermore, resistance training upregulates the expression and function of amino acid transporters, including system L amino acid transporter 1 (LAT1) and sodium-coupled neutral amino acid transporter 2 (SNAT2), which are essential for leucine and glutamine uptake respectively [24]. This enhanced transport capacity allows the muscle to more effectively extract amino acids from the circulation, partially compensating for age-related reductions in transporter efficiency.

Finally, resistance training induces neuroplasticity adaptations that increase motor unit recruitment and firing frequency, leading to enhanced muscle fiber activation. These neural adaptations occur within days to weeks of training initiation and contribute significantly to early strength gains, even before measurable hypertrophy occurs [25]. Meta-analyses consistently demonstrate that resistance training improves muscle mass, strength, and functional capacity in older adults [26]. Importantly, strength gains often exceed mass gains, suggesting improvements in muscle quality and neural control beyond simple hypertrophy.

Optimized protein nutrition

Protein nutrition must be tailored to overcome the elevated anabolic threshold characteristic of aging muscle. This requires both adequate total intake and optimal distribution throughout the day. Clinical evidence supports protein intake of 1.2-1.6 g/kg/day for older adults, substantially higher than the current RDA of 0.8 g/kg/day [27]. Since muscle protein synthesis has a ceiling effect, it's important to spread protein intake evenly throughout the day rather than loading up at one meal. Each meal should contain approximately 0.4 g/kg of high-quality protein to achieve maximal anabolic stimulation [13]. This typically translates to 25-30 grams of protein per meal for most older adults.

High-quality proteins containing adequate leucine content (2.5-3.0 grams per meal) are essential for optimal MPS stimulation [28,29]. Animal-based proteins generally provide superior amino acid profiles compared to plant-based alternatives, although properly combined plant proteins can achieve similar effects [30].

Synergistic effects of combined interventions

The combination of resistance training and optimized protein nutrition produces synergistic effects that exceed the sum of individual interventions. Resistance training sensitizes the muscle to amino acid stimulation, while adequate protein provides the necessary substrate for enhanced MPS responses. This interaction works through both immediate and longterm mechanisms that reinforce each other. Meta-analyses demonstrate that protein supplementation augments resistance training-induced muscle mass gains by approximately 38% beyond training alone, with particularly strong effects in older adults [31]. The timing of this synergy is critical, occurring within the 24-48 hour post-exercise period when exerciseinduced mTOR priming and upregulated amino acid transporter expression maximize protein utilization [24].

Combined interventions also show superior functional benefits, with improvements in walking speed, chair rise time, and daily activities exceeding single interventions by over 20% [26]. The synergistic response depends on adequate dosing, with peak benefits seen at protein intakes of 1.4-1.6 g/kg/day paired with resistance training 2-3 times weekly [13].

Long-term application of combined interventions leads to adaptations beyond immediate anabolic responses. These include metabolic changes in muscle tissue, increased mitochondrial activity, and better insulin sensitivity, all of which support ongoing anabolic processes [6,20]. These findings highlight why comprehensive approaches are essential for addressing anabolic resistance. Clinicians who apply these synergistic principles can achieve better outcomes in preventing age-related muscle loss and maintaining functional capacity in older adults.

Adjuvant Therapies

Creatine monohydrate

Creatine monohydrate represents the most evidence-based nutritional supplement for augmenting resistance training effects in older adults [32]. By increasing intramuscular phosphocreatine stores, creatine enhances high-intensity exercise capacity, allowing for greater training volumes and improved anabolic stimulation.

Vitamin D

Vitamin D supplementation provides benefits primarily in deficient individuals, correcting impaired muscle function rather than enhancing normal physiology [33]. Given the high prevalence of vitamin D deficiency in older adults, screening and supplementation represent important clinical considerations.

Clinical Implementation Challenges

Adherence and compliance

Implementing evidence-based interventions for anabolic resistance faces significant practical challenges. Resistance training requires supervised instruction, progressive overload, and long-term commitment. Protein distribution requires substantial dietary modification and ongoing monitoring.

Individual variability

Substantial individual variation exists in anabolic resistance severity and intervention responsiveness. Factors including genetics, comorbidities, medication use, and baseline fitness levels all influence treatment outcomes [4]. Personalized approaches may be necessary for optimal results.

Healthcare system integration

Current healthcare systems often lack infrastructure for implementing comprehensive anabolic resistance interventions. Integration of exercise professionals, dietitians, and physicians is essential for successful outcomes but remains challenging in many settings.

Conclusions

Anabolic resistance is now widely recognized as a pivotal mechanism driving the onset and progression of sarcopenia in older adults. Characterized by a diminished sensitivity to anabolic stimuli and an elevated threshold for muscle protein synthesis, this condition undermines the effectiveness of standard nutritional and exercise-based interventions. Its impact extends beyond muscle atrophy, contributing to declines in mobility, independence, and overall quality of life.

Clinical evidence supports a multi-tiered strategy to mitigate anabolic resistance. At the core is progressive resistance training, which transiently restores anabolic sensitivity and primes skeletal muscle for nutrient responsiveness. When combined with optimized protein intake—specifically 1.2 to 1.6 g/kg/day evenly distributed across meals—this approach can significantly enhance muscle protein synthesis in aging individuals. Creatine supplementation may offer additive benefits, particularly in enhancing the efficacy of resistance training protocols.

Crucially, effective implementation requires individualized approaches that consider comorbidities, physical capacity, and nutritional status. Moreover, overcoming anabolic resistance should not be viewed as a rehabilitative goal alone, but rather as a preventive strategy central to healthy aging.

Future research priorities include developing accessible diagnostic tools, identifying personalized treatment approaches, and investigating novel therapeutic targets. By advancing our understanding of anabolic resistance, we can develop more effective strategies to maintain muscle health and functional independence throughout the aging process.

Notes

Acknowledgments

This work was supported by Soonchunhyang university research fund.

The author declares no conflicts of interest.

References

1. Yuan S, Larsson SC. Epidemiology of sarcopenia: prevalence, risk factors, and consequences. Metabolism 2023;144:155533.
2. Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2019;48(1):16–31.
3. Breen L, Phillips SM. Skeletal muscle protein metabolism in older adults: interventions to counteract the ‘anabolic resistance’ of ageing. Nutr Metab (Lond) 2011;8:68.
4. Paulussen KJM, McKenna CF, Beals JW, Wilund KR, Salvador AF, Burd NA. Anabolic resistance of muscle protein turnover comes in various shapes and sizes. Front Nutr 2021;8:615849.
5. Prokopidis K, Chambers E, Ni Lochlainn M, Witard OC. Mechanisms linking the gut-muscle axis with muscle protein metabolism and anabolic resistance: implications for older adults at risk of sarcopenia. Front Physiol 2021;12:770455.
6. Tezze C, Sandri M, Tessari P. Anabolic resistance in the pathogenesis of sarcopenia in older adults: role of nutrition and exercise in young and old people. Nutrients 2023;15(18):4073.
7. Wall BT, Gorissen SH, Pennings B, et al. Aging is accompanied by a blunted muscle protein synthetic response to protein ingestion. PLoS One 2015;10(11)e0140903.
8. Banks NF, Rogers EM, Church DD, Ferrando AA, Jenkins NDM. The contributory role of vascular health in age-related anabolic resistance. J Cachexia Sarcopenia Muscle 2022;13(1):114–27.
9. Moore DR. Keeping older muscle “young” through dietary protein and physical activity. Adv Nutr 2014;5(5):599S–607S.
10. Landers-Ramos RQ, Prior SJ. The microvasculature and skeletal muscle health in aging. Exerc Sport Sci Rev 2018;46(3):172–9.
11. Hiol AN, von Hurst PR, Conlon CA, Beck KL. Associations of protein intake, sources and distribution on muscle strength in community-dwelling older adults living in Auckland, New Zealand. J Nutr Sci 2023;12e94.
12. Morgan PT, Harris PO, Marshall RN, et al. Protein source and quality for skeletal muscle anabolism in young and older adults: a systematic review and meta-analysis. J Nutr 2021;151(7):1901–20.
13. Bauer J, Biolo G, Cederholm T, et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc 2013;14(8):542–59.
14. Breen L, Stokes KA, Churchward-Venne TA, et al. Two weeks of reduced activity decreases leg lean mass and induces “anabolic resistance” of myofibrillar protein synthesis in healthy elderly. J Clin Endocrinol Metab 2013;98(6):2604–12.
15. Biolo G, Pišot R, Mazzucco S, et al. Anabolic resistance assessed by oral stable isotope ingestion following bed rest in young and older adult volunteers: relationships with changes in muscle mass. Clin Nutr 2017;36(5):1420–6.
16. Tatiana M, Brightwell CR, Deer RR, et al. Muscle protein anabolic resistance to essential amino acids does not occur in healthy older adults before or after resistance exercise training. J Nutr 2018;148(6):900–9.
17. Siddik MAB, Shin AC. Recent progress on branched-chain amino acids in obesity, diabetes, and beyond. Endocrinol Metab 2019;34(3):234–46.
18. Ardeljan AD, Hurezeanu R. Sarcopenia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2023; https://www.ncbi.nlm.nih.gov/books/NBK560813/.
19. Burd NA, West DW, Moore DR, et al. Enhanced amino acid sensitivity of myofibrillar protein synthesis persists for up to 24 h after resistance exercise in young men. J Nutr 2011;141(4):568–73.
20. Aragon AA, Tipton KD, Schoenfeld BJ. Age-related muscle anabolic resistance: inevitable or preventable? Nutr Rev 2023;81(4):441–54.
21. Rogeri PS, Zanella R Jr, Martins GL, et al. Strategies to prevent sarcopenia in the aging process: role of protein intake and exercise. Nutrients 2021;14(1):52.
22. Drummond MJ, Dreyer HC, Pennings B, et al. Skeletal muscle protein anabolic response to resistance exercise and essential amino acids is delayed with aging. J Appl Physiol 2008;104(5):1452–61.
23. McGlory C, Devries MC, Phillips SM. Skeletal muscle and resistance exercise training; the role of protein synthesis in recovery and remodeling. J Appl Physiol 2017;122(3):541–8.
24. Mazzulla M, Hodson N, Lees M, et al. LAT1 and SNAT2 protein expression and membrane localization of LAT1 are not acutely altered by dietary amino acids or resistance exercise nor positively associated with leucine or phenylalanine incorporation in human skeletal muscle. Nutrients 2021;13(11):3906.
25. Aslam S, Habyarimana JDD, Bin SY. Neuromuscular adaptations to resistance training in elite versus recreational athletes. Front Physiol 2025;16:1598149.
26. Liao CD, Chen HC, Lin HT, Tsauo JY, Liou TH, Huang SW. Effects of elastic resistance exercise on muscle strength and functional performance in healthy adults: a systematic review and meta-analysis. Ann Phys Rehabil Med 2017;60(5):339–48.
27. Morton RW, Murphy KT, McKellar SR, et al. A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults. Br J Sports Med 2018;52(6):376–84.
28. Gielen E, Beckwée D, Delaere A, et al. Nutritional interventions to improve muscle mass, muscle strength, and physical performance in older people: an umbrella review of systematic reviews and meta-analyses. Nutr Rev 2021;79(2):121–47.
29. Volpi E. Is leucine content in dietary protein the key to muscle preservation in older women? Am J Clin Nutr 2018;107(2):143–4.
30. Carbone JW, Pasiakos SM. The role of dietary plant and animal protein intakes on mitigating sarcopenia risk. Curr Opin Clin Nutr Metab Care 2022;25(6):425–9.
31. Cermak NM, Res PT, de Groot LC, Saris WH, van Loon LJ. Protein supplementation augments the adaptive response of skeletal muscle to resistance-type exercise training: a meta-analysis. Am J Clin Nutr 2012;96(6):1454–64.
32. Buford TW, Kreider RB, Stout JR, et al. International Society of Sports Nutrition position stand: creatine supplementation and exercise. J Int Soc Sports Nutr 2007;4:6.
33. Uchitomi R, Oyabu M, Kamei Y. Vitamin D and sarcopenia: potential of vitamin D supplementation in sarcopenia prevention and treatment. Nutrients 2020;12(10):3189.

Article information Continued

Figure 1.

Mechanistic Pathways Underlying Anabolic Resistance in Aging Skeletal Muscle.